Stagno J, Deme J, Dwivedi V, Lee Y, Lee H, Yu P
Nucleic Acids Res. 2025; 53(5).
PMID: 40071935
PMC: 11897892.
DOI: 10.1093/nar/gkaf156.
Dai G, Cheng J, Liu W, Yin X, Zhang Y
Int J Mol Sci. 2025; 26(3).
PMID: 39940931
PMC: 11817826.
DOI: 10.3390/ijms26031163.
Nomura Y, Kim N, Zhu B, Hamzah M, Zhang H, Yokobayashi Y
ACS Synth Biol. 2024; 13(10):3246-3255.
PMID: 39318128
PMC: 11494654.
DOI: 10.1021/acssynbio.4c00295.
Luo L, Jea J, Wang Y, Chao P, Yen L
Nat Biotechnol. 2024; 42(9):1454-1466.
PMID: 38168982
DOI: 10.1038/s41587-023-01989-0.
Nat Biotechnol. 2024; 42(9):1366-1367.
PMID: 38168981
DOI: 10.1038/s41587-023-02020-2.
Tapping the potential of synthetic riboswitches: reviewing the versatility of the tetracycline aptamer.
Kelvin D, Suess B
RNA Biol. 2023; 20(1):457-468.
PMID: 37459466
PMC: 10353319.
DOI: 10.1080/15476286.2023.2234732.
Small-Molecule Aptamer for Regulating RNA Functions in Mammalian Cells and Animals.
Fukunaga K, Dhamodharan V, Miyahira N, Nomura Y, Mustafina K, Oosumi Y
J Am Chem Soc. 2023; 145(14):7820-7828.
PMID: 36991533
PMC: 10103173.
DOI: 10.1021/jacs.2c12332.
Therapeutic immunomodulation by rationally designed nucleic acids and nucleic acid nanoparticles.
Panigaj M, Skelly E, Beasock D, Marriott I, Johnson M, Salotti J
Front Immunol. 2023; 14:1053550.
PMID: 36798121
PMC: 9927404.
DOI: 10.3389/fimmu.2023.1053550.
Novel Design of RNA Aptamers as Cancer Inhibitors and Diagnosis Targeting the Tyrosine Kinase Domain of the NT-3 Growth Factor Receptor Using a Computational Sequence-Based Approach.
Muhammad A, Zari A, Alsubhi N, Al-Zahrani M, Alghamdi R, Labib M
Molecules. 2022; 27(14).
PMID: 35889390
PMC: 9320020.
DOI: 10.3390/molecules27144518.
Aptamer-Array-Guided Protein Assembly Enhances Synthetic mRNA Switch Performance.
Lu Q, Hu Y, Yin Li C, Kuang Y
Angew Chem Int Ed Engl. 2022; 61(34):e202207319.
PMID: 35703374
PMC: 9544043.
DOI: 10.1002/anie.202207319.
Premature translation termination mediated non-ER stress induced ATF6 activation by a ligand-dependent ribosomal frameshifting circuit.
Hsu H, Murata A, Dohno C, Nakatani K, Chang K
Nucleic Acids Res. 2022; 50(9):5369-5383.
PMID: 35511080
PMC: 9122530.
DOI: 10.1093/nar/gkac257.
Protein-Based Systems for Translational Regulation of Synthetic mRNAs in Mammalian Cells.
Nakanishi H
Life (Basel). 2021; 11(11).
PMID: 34833067
PMC: 8621430.
DOI: 10.3390/life11111192.
Cell-free riboswitches.
Tabuchi T, Yokobayashi Y
RSC Chem Biol. 2021; 2(5):1430-1440.
PMID: 34704047
PMC: 8496063.
DOI: 10.1039/d1cb00138h.
Self-cleaving ribozymes: substrate specificity and synthetic biology applications.
Peng H, Latifi B, Muller S, Luptak A, Chen I
RSC Chem Biol. 2021; 2(5):1370-1383.
PMID: 34704043
PMC: 8495972.
DOI: 10.1039/d0cb00207k.
Controlling Gene Expression in Mammalian Cells Using Multiplexed Conditional Guide RNAs for Cas12a*.
Oesinghaus L, Simmel F
Angew Chem Int Ed Engl. 2021; 60(44):23894-23902.
PMID: 34533878
PMC: 8596743.
DOI: 10.1002/anie.202107258.
A kinetically controlled platform for ligand-oligonucleotide transduction.
Zhang Q, Wang L, Liu Y, Lin J, Xu L
Nat Commun. 2021; 12(1):4654.
PMID: 34341342
PMC: 8329073.
DOI: 10.1038/s41467-021-24962-4.
Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors.
Tickner Z, Farzan M
Pharmaceuticals (Basel). 2021; 14(6).
PMID: 34200913
PMC: 8230432.
DOI: 10.3390/ph14060554.
Context-aware synthetic biology by controller design: Engineering the mammalian cell.
Shakiba N, Jones R, Weiss R, Del Vecchio D
Cell Syst. 2021; 12(6):561-592.
PMID: 34139166
PMC: 8261833.
DOI: 10.1016/j.cels.2021.05.011.
Prebiotic Pathway from Ribose to RNA Formation.
Banfalvi G
Int J Mol Sci. 2021; 22(8).
PMID: 33917807
PMC: 8068141.
DOI: 10.3390/ijms22083857.
Engineered CRISPR/Cas13d Sensing hTERT Selectively Inhibits the Progression of Bladder Cancer .
Zhuang C, Zhuang C, Zhou Q, Huang X, Gui Y, Lai Y
Front Mol Biosci. 2021; 8:646412.
PMID: 33816560
PMC: 8017217.
DOI: 10.3389/fmolb.2021.646412.